Global expansion Codis has completed the acquisition of Catalent's Nottingham facility and expanded its European footprint, signaling a growing demand for end-to-end spray drying capabilities and regional manufacturing presence in Europe. This creates sales opportunities for localized CDMO services, tech transfer, and supply chain resilience for European clients.

Spray drying leadership The company emphasizes expertise in spray drying, amorphous solid dispersions and particle engineering, positioning Codis as a preferred partner for complex formulation development and high-performance ASD products, appealing to pharma companies seeking advanced manufacturing solutions.

Strategic leadership New executive appointments and a strong management team, including a General Manager for the Nottingham site and a dedicated VP of Sales & Marketing for Haverhill, indicate a focused go-to-market strategy and increased effectiveness in pursuing high-value CDMO contracts.

Investment momentum Growth investments from 1315 Capital and participation from BroadOak and RCT, along with ongoing facility expansions, signal financial stability and a capital-backed growth trajectory that can support larger scale projects, long-term outsourcing commitments, and capacity commitments from potential clients.

Industry positioning Codis operates as a global, niche CDMO with capabilities in finished-dose manufacturing and advanced particle engineering, appealing to pharmaceutical companies seeking integrated development-to-scale manufacturing, reduced time-to-market, and reliable regulatory performance for ASD-based products.